SCHEMBL26106955

SCHEMBL26106955

Cn1c(C2=CCC3(CC2)CCN(C=CC=O)CC3)c(-c2ccc(OCCN3CCCC3)cc2)c2c(N)ncnc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.38
▸ ADORA1 P30542 3/20 0.38
▸ ADORA3 P0DMS8 2/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ TNK2 Q07912 6/20 0.35
▸ LCK P06239 4/20 0.35
▸ KDR P35968 3/20 0.35
▸ JAK3 P52333 3/20 0.35
▸ ACHE P22303 3/20 0.35
▸ TEK Q02763 1/20 0.35
▸ EGFR P00533 2/20 0.34
▸ SRC P12931 2/20 0.34
▸ ZAP70 P43403 2/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ LTA4H P09960 2/20 0.34
▸ HRH3 Q9Y5N1 3/20 0.33
▸ ADRA1A P35348 2/20 0.33
▸ KCNH2 Q12809 2/20 0.33
▸ ESR1 P03372 2/20 0.33
▸ NTRK1 P04629 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26108002 0.89 SRC (0.37) LCKKDRTEKEGFRSRC
SCHEMBL26109846 0.87 KCNH2 (0.36) LCKKDRTEKEGFRKCNH2
SCHEMBL26109416 0.86 ADORA3 (0.40) ADORA2AADORA1ADORA3ADORA2BTNK2
SCHEMBL26105801 0.86 PTPN11 (0.35) LCKKDRTEKEGFRFLT3
SCHEMBL26108781 0.86 BTK (0.35) KDRTEKEGFR
SCHEMBL26109060 0.85 BTK (0.35) LCKKDRTEKEGFRFLT3
SCHEMBL30582517 0.85 FGFR1 (0.46) —
SCHEMBL30582575 0.83 SRC (0.40) ADORA2AADORA1ADORA3ADORA2BEGFR
SCHEMBL26107738 0.83 SRC (0.40) ADORA2AADORA1ADORA3ADORA2BEGFR
SCHEMBL26109353 0.82 RET (0.32) KDREGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO claimed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback